Swiss group Straumann took over the Romanian firm Artis Bio Tech, lively on the dental market and managed by three native entrepreneurs – Ion Nicolescu, Manuela Agatstein, and Nicolae Nicolescu, Ziarul Financiar reported.
The worth of the deal was not made public.
“Artis is a household enterprise, a model constructed within the final 15 years,” says Ion Nicolescu, Artis’ most important shareholder.
Artis Bio Tech has been lively for 15 years available in the market for the distribution of implantology merchandise.
The Artis Bio Tech enterprise has grown steadily, however strongly lately.
Particularly, the corporate’s turnover doubled between 2017 and 2019 to RON 21 million (EUR 4 mln).
The revenue additionally doubled to RON 6.3 mln (EUR 1.3 mln) final yr.
The Straumann Group in Switzerland, with an annual turnover of over EUR 1.4 billion, is a supplier of full options for beauty dentistry.
The Swiss firm is a pacesetter in dental implant techniques and has workplaces in over 100 nations.
(Photograph: Petr Smagin | Dreamstime.com)